Gleason sum upgrading (GSU) is common in patients with organ-confined prostate cancer. Studies in 2010 have identified GSU predictors and examined the role of GSU in patients with prostate cancer, but several clinical applications for GSU have been suggested—has its clinical importance in daily practice been inflated?
- Umberto Capitanio
- Nazareno Suardi
